Investigating the effect of DermatoTreat spray in the treatment of dermatophytosis
- Conditions
- Dermatophytosis.Dermatophytosis
- Registration Number
- IRCT20230816059161N1
- Lead Sponsor
- Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 98
All the dermatophytosis patients who were diagnosed by physical exam by doctor or by routine mycological methods
Availability for the duration of the study (6 weeks)
Male or female, 18 years or older
Willingness to follow the study protocol
Not taking systemic antifungal drugs in the last month
Not using topical anti-fungal drugs or anti-fungal shampoo in 2 weeks before treatment
Insensitivity to terbinafine
Informed consent
Moccasin-type tinea pedis
Tinea capitis , tinea with an area of more than 20% of the body
Tinea resistant to previous treatments including oral treatment and Tinea incognito
Severe maceration of interdigital spaces
Severe fissuring
Prescribing or taking oral antifungal medication in the two weeks before or during the study
History of dry feet, cracks, fissures
Concomitant onychomycosis
Serous discharge or pus
Concomitant immunosuppressive or antimicrobial therapy
Failure to respond to treatment
Drug allergy
Failure to cooperate with the doctor
Pregnant and lactating women
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Effective treatment (fungal treatment and minimal symptoms). Timepoint: In the beginning, 1, 2 and 4 weeks after the initiation of therapy. Method of measurement: Microscopic examination (direct smear exam) and clinical evaluation that is based on a total of 6 symptoms (skin peeling, vesiculation, erythema, fissure, soaking and itching) which is recorded by the physician.
- Secondary Outcome Measures
Name Time Method